Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New muscarinic antagonists from Schering-Plough

Oct. 11, 1996

Potential antipsychotic agents disclosed by Pharmacia & Upjohn

Oct. 11, 1996

Dopamine D3 ligands from Pharmacia & Upjohn

Oct. 11, 1996

New dopamine receptor ligands reported by Neurogen

Oct. 11, 1996

Suntory reports agents for CNS and cerebrovascular disorders

Oct. 11, 1996

Japanese researchers report new antimetastatic agents

Oct. 11, 1996

DuPont Merck describes bisnaphthalimide anticancer drugs

Oct. 11, 1996

Farnesyltransferase inhibitors discovered by RPR

Oct. 11, 1996

Chemokine polypeptide from Human Genome Sciences has multiple potential uses

Oct. 11, 1996

Endorecherche claims EM-800 for estrogen-dependent disorders

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....